Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
AGC Biologics expands its partnership with Novelty Nobility to manufacture a bispecific antibody in Japan.
-
- Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base - Company announces further operational progress in its Comprehensive...
-
Enrollment completed in ML-007C-MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2...
-
The global GM foods market is projected to grow from $388.4 billion in 2025 to $451.6 billion by 2030, driven by rising food, feed, and protein demand.
-
SAN FRANCISCO, U.S. / LONDON, UK, April 30, 2026 (GLOBE NEWSWIRE) -- Living Carbon PBC, a climate technology company, has signed a major deal with leading specialist renewable investor Octopus...
-
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB: OTLC), a clinical-stage biotechnology company focused on oncology and...
-
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care...
-
Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Technical Writing for Med Devices, Pharma and Biotech (July 20th - July 23rd, 2026)" training has been added to ResearchAndMarkets.com's...
-
DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a...
-
MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...